QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed
Clinical trial NCT03387111 · TERMINATED
Trial details
- NCT number
- NCT03387111
- Sponsor
- ImmunityBio, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-09
- Primary completion
- 2019-04-17
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.